IMMIX BIOPHARMA, INC.

Profile

Company Names

IMMIX BIOPHARMA, INC.

Addresses

11400 W OLYMPIC BLVD, SUITE 200, LOS ANGELES, CA 90064

Phone Numbers

(310) 651-8041

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$0.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-05-20 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HELEN C. 
 
ADAMS 
DIRECTOR
IMMIX BIOPHARMA, INC.
JANE 
 
BUCHAN 
DIRECTOR
BLACK DIAMOND STRUCTURED OPPORTUNITIES LTD   |  BLACK DIAMOND RELATIVE VALUE LTD   |  BLACK DIAMOND LTD   |  BLACK DIAMOND ARBITRAGE LTD   |  DOUBLE BLACK DIAMOND LTD   |  BLACK DIAMOND THEMATIC LTD.   |  BLACK DIAMOND RELATIVE VALUE LTD.   |  BLACK DIAMOND LTD.   |  BLACK DIAMOND ARBITRAGE LTD.   |  DOUBLE BLACK DIAMOND LTD.   |  BLACK DIAMOND SRI LTD.   |  BLACK DIAMOND ENERGY L/S LTD.   |  IMMIX BIOPHARMA, INC.
YEKATERINA 
 
CHUDNOVSKY 
DIRECTOR
ELICIO THERAPEUTICS, INC.   |  ELICIO THERAPEUTICS, INC.   |  IMMIX BIOPHARMA, INC.
JASON 
 
HSU 
DIRECTOR
ROBOTDOUGH SOFTWARE CORP   |  IMMIX BIOPHARMA, INC.
MAGDA 
 
MARQUET 
DIRECTOR
ALTHEADX, INC.   |  ALTHEA TECHNOLOGIES INC   |  SENTE INC   |  INDEPENDA, INC.   |  ALUME BIOSCIENCES INC   |  PROCISEDX INC.   |  MATRISYS BIOSCIENCE, INC.   |  IMMIX BIOPHARMA, INC.   |  TRANSCODE THERAPEUTICS, INC.   |  ACURION, INC.
GABRIEL 
 
MORRIS 
EXECUTIVE OFFICER, DIRECTOR
IMMIX BIOPHARMA, INC.
CAREY 
 
NG 
DIRECTOR
PARADIGM DIAGNOSTICS, INC.   |  MESA VERDE VENTURE PARTNERS III, L.P.   |  ELYSIUM THERAPEUTICS, INC.   |  MESA VERDE VENTURE PARTNERS IV, LP   |  MATRISYS BIOSCIENCE, INC.   |  IMMIX BIOPHARMA, INC.
ILYA 
 
RACHMAN 
EXECUTIVE OFFICER, DIRECTOR
IMMIX BIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-05-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE